BridgeMD
New treatment option for Biliary Tract Carcinoma
Official title Intraductal Radiofrequency Thermoablation and Radiotherapy Combined Treatment for Extrahepatic Cholangiocarcinoma
ClinicalTrials.gov ID: NCT06168292
What this study is testing
- What it's testing
- [Study objectives] To evaluate the efficacy and safety of the combined treatment of radiotherapy and endoscopic intraductal radiofrequency ablation in patients with locoregional extrahepatic cholangiocarcinoma.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 and older
You may be able to join if
- Patients 20 years of age or older, who voluntarily agree to participate in the study and sign the informed consent.
- Patients with cytopathologically diagnosed inoperable extrahepatic cholangiocarcinoma
You likely can't join if
- Patients who refuse to sign the informed consent
- Patients with metastatic cancer (stage IV) or malignant ascites
- Patients with intrahepatic cholangiocarcinoma
- Patients who are unable to undergo endoscopic procedures as determined by the investigator.
- Patients with a life expectancy of 3 months or less
- Patients with ID-RFA contraindications: pacemaker, pregnancy, uncorrected bleeding tendency (PT INR \> 1.5, platelets \< 50,000/mm3)
The study team makes the final eligibility decision.
Where it's taking place
- Goyang-si, Other, South Korea
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 20 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Goyang-si, Other, South Korea. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.